Cardiovascular effects of antidepressants: studies of paroxetine in healthy men and depressed patients
- PMID: 1431013
Cardiovascular effects of antidepressants: studies of paroxetine in healthy men and depressed patients
Abstract
The classical tricyclic antidepressant drugs effectively relieve the symptoms of depression, but they have the potential to be severely toxic to the cardiovascular system--including postural hypotension after therapeutic doses and lethal arrhythmias after overdosage. Paroxetine has been shown to be of similar efficacy to the tricyclic antidepressants but has lower cardiovascular toxicity in animal models and has no effects on heart rate, blood pressure or the electrocardiogram in healthy men receiving single 20-40 mg doses. The results of two contrasting studies in depressive patients and healthy men provide strong evidence that therapeutic doses of paroxetine lack any important haemodynamic or electrophysiological effects.
Similar articles
-
Heart rate variability in depressed patients and differential effects of paroxetine and amitriptyline on cardiovascular autonomic functions.Pharmacopsychiatry. 1994 May;27(3):124-8. doi: 10.1055/s-2007-1014291. Pharmacopsychiatry. 1994. PMID: 8078953 Clinical Trial.
-
Monoamine oxidase inhibitors and tricyclic antidepressants: comparison of their cardiovascular effects.J Clin Psychiatry. 1986 May;47(5):225-9. J Clin Psychiatry. 1986. PMID: 3516976 Review.
-
Paroxetine: an overview of the efficacy and safety of a new selective serotonin reuptake inhibitor in the treatment of depression.J Clin Psychopharmacol. 1993 Dec;13(6 Suppl 2):10S-17S. J Clin Psychopharmacol. 1993. PMID: 8106649 Review.
-
Effects of chronic desipramine on plasma norepinephrine concentrations and cardiovascular parameters in elderly depressed women: a preliminary report.Biol Psychiatry. 1984 Apr;19(4):549-56. Biol Psychiatry. 1984. PMID: 6733174
-
Cardiovascular effects of imipramine, fluvoxamine, and placebo in depressed outpatients.J Clin Psychiatry. 1993 Jun;54(6):224-8. J Clin Psychiatry. 1993. PMID: 8331091 Clinical Trial.
Cited by
-
Spotlight on paroxetine in psychiatric disorders in adults.CNS Drugs. 2002;16(6):425-34. doi: 10.2165/00023210-200216060-00006. CNS Drugs. 2002. PMID: 12027788 Review.
-
Paroxetine controlled release.CNS Drugs. 2004;18(6):355-64; discussion 365-6. doi: 10.2165/00023210-200418060-00003. CNS Drugs. 2004. PMID: 15089103 Review.
-
Paroxetine. An update of its pharmacology and therapeutic use in depression and a review of its use in other disorders.Drugs. 1998 Jan;55(1):85-120. doi: 10.2165/00003495-199855010-00007. Drugs. 1998. PMID: 9463792 Review.
-
Paroxetine: an update of its use in psychiatric disorders in adults.Drugs. 2002;62(4):655-703. doi: 10.2165/00003495-200262040-00010. Drugs. 2002. PMID: 11893234 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources